COVID-X is an initiative that will invest 4 million € to fast-track to market 30+ European data technology solutions defeating COVID-19 Challenges, facilitating an innovative stack of AI-driven tools.

COVID-X will fund EU Companies and Healthcare Providers to boost data-driven solutions with the power to overcome challenges in Diagnosis, Prognosis, and Follow-up. The funding is invested in products with TRL 7+ and [or in the process of] CE marking, covering two profiles: Single players (EU Tech SMEs / Start-Ups) validating their solutions at one of COVID-X clinical partners; or Team players (Tech Provider working with a Healthcare provider that will validate the solution).

The selected projects will join an Acceleration Program to boost their quick market uptake. This will include technical support, ethical validation, and business coaching. In addition, participants will have access to the COVID-X Sandbox.

Deadline: 27th January 2021: https://www.covid-x.eu/